Brief: Cynata Advances Planned Clinical Trial In Diabetic Foot Ulcers In MoU With Tekcyte
March 1 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* CYNATA ADVANCES PLANNED CLINICAL TRIAL IN DIABETIC FOOT
ULCERS
IN MOU WITH TEKCYTE
* CYNATA THERAPEUTICS LTD - PLANS TO UNDERTAKE CLINICAL
TRIAL OF
ITS CYMERUS MSC PRODUCT BASED ON PRE-CLINICAL FOUNDATION,
UTILISING TEKCYTE TECHNOLOGY
* CYNATA THERAPEUTICS LTD - TEKCYTE WILL WORK WITH CYNATA TO
MANUFACTURE AND SUPPLY ACTIVE DRESSING FOR PLANNED CLINICAL
TRIAL
Source text for Eikon: ID:nGNX13chxc
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million